Drug Pipeline

ZL-1310 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
1
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT07218146
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed…		 Trial sites expanded: 34 -> 56 locations
Active Studies by Phase
Phase 3
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07218146 A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed… Small-cell Lung Cancer Recruiting
Phase 1/2
NCT06885281 A Study of ZL-1310 in Participants With Selected Solid Tumors Solid Tumors Recruiting
Phase 1
NCT06179069 A Study of ZL-1310 in Subjects With Small Cell Lung Cancer SCLC Recruiting
NCT07531095 Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small… Small Cell Lung Cancer Recruiting
Sponsors Running ZL-1310 Trials
Zai Lab (Shanghai) Co., Ltd. (3) Amgen (1)
Disease Areas
Small Cell Lung Cancer (2) Lung Cancer (2)
Get alerts when ZL-1310 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free